🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Mark A. Matza, MD, MBA, RhMSUS Anisha Dua MGH Rheumatology USSONAR Arthur Mandelin, MD/PhD, RhMSUS, RMSK Looking for a reference for #ultrasound in #vasculitis? Updated chapter by AndreasD link.springer.com/chapter/10.100… #POCUS Vasculitis 2022 Vasculitis Foundation USSONAR #ACR21

It is with immense sadness that we announce the death of our co-director, the irreplaceable Professor Justin Mason An online memorial board has been set up for staff, students and peers to share their messages and memories of Professor Justin Mason ow.ly/iuiZ50JhkY5

Here is our analysis of the data quality from the FAIRVASC ANCA-associated vasculitis registries to date. Horizon Europe 🇪🇺 🇪🇺

A pleasure to host Dr Brad Rovin Ohio State Nephrology who answered important questions on LN treatment Gunnar Henrik Heine Lupus Foundation of America Lupus UK youtu.be/c67zLEqtYmM via YouTube

Pt w/RPGN picture, Cr 1.1 3mo prior, arrived w/Cr 4, prot/hem in urine, MPO+ANCA, DAH, AKI-RRT. Deemed too sick for biopsy. Started CS,PLEX, RTX/CYC (RITUXIVAS). 2 wks later, transfers to you, Spun urine RBC casts, still AKI-RRT. 2nd dose RTX/CYC due. You would (vote and comment)

If you'd like to know a little more about the inner machinations of FAIRVASC then check out this short interview I did with our communications team #anca #vasculitis #registry #data 😀

The EUVAS Registries Group of FAIRVASC research is led by Prof. Mark Little, Trinity College Dublin. They have identified over 11,000 AAV cases in European national registries and defined a common data dictionary. fairvasc.eu/registries/

Rigorous clinical research relies on the analysis of sufficiently large numbers of patients, samples, measurements etc. to allow reliable statistical inference. The low prevalence of #rarediseases and thus patient numbers represent a major barrier to such research. #vasculitis

🆕Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study Interesting🤔➡️ Should lead to some RCTs #MedTwitter #RheumTwitter #Vasculitis ard.bmj.com/content/early/…

Sequential therapy with #rituximab and #mepolizumab for #EGPA: efficacy demonstrated in a retrospective multicenter study of 38 patients. bit.ly/3aYtvAK

More than grateful that Rheumatology & Rheumatology Advances in Practice invited us to write an Editorial on a very informative paper from Korea (academic.oup.com/rheumatology/a…) about the 2022 classification of GPA. Evolvement of classification criteria has been summarized in this table (see below) academic.oup.com/rheumatology/a…

Can’t believe we haven’t studied this properly before - Duvuru Geetha sees reduction in #vasculitis relapse in people given #immunoglobulin for hypoglobulinemia. Tiny series but merits validation. doi.org/10.1016/j.kint…

Dr. Sebastian Unizony, codirector of the #vasculitis center at MGH presents the PANLAR guidelines for Giant Cell Arteritis #GCA MGH Rheumatology MGH_Rheum_Vasculitis Vasculitis Foundation Vasculitis 2022 #rheumtwitter #rheumatology #Meded

So let me get this straight: @KwasiKwarteng & Liz Truss are putting more £ in our pockets so we can pay more for #mortgages, more for anything imported as the £ goes into free fall & have even more underfunding of #PublicSector services? In what universe is any of this good?

There are many important gaps in our knowledge about why and how #vasculitis occurs, why some people seem to be more susceptible than others, how the disease process acts inside the body and whether different kinds of vasculitis should be treated in different ways. Meet FAIRVASC

ATTENTION! People w #RareDiseases and #Patientadvocates in the wider FAIRVASC family👪👩‍👧‍👧👨‍👧 📅The deadline is tomorrow to apply to attend Rare Disease Week 2023 in #Brussels at no cost! As it says on the tin🥫: Empower your future self today!

Save the dates everybody. Barcelona 2024! #vasculitis

Prof. Cees Kallenberg from University of Groningen ia giving us the opportunity to take stock of current understanding on #vasculitis here at #EUVAS2022 in #Florence EUVAS Università di Firenze KDIGO Cambridge University @VasculitisUMCG Vasculitis 2022 #AAV #NephTwitter #KidneyDisease

2024 Vasculitis Meeting will be in Barcelona! Save the date - April 7-10th, 2024 :) #ACR22 #Vasculitis22 #ACRAmbassador

Join us on Friday, March 3, 2023 for the #complimentary virtual program '#ANCA #Vasculitis: Update on Diagnosis & Treatment' Registration: eventleaf.com/e/ANCA2023 #IgAN #Kidney #NephTwitter #NephPearls #KidneyTwitter #Renal #Medicine #MedEd #MedTwitter #Physician #Doctor